168412-06-4

Upstream product

• 99686-99-4 1-benzyl-5-methyl-4-nitro-1H-imidazole 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 100-44-7 benzyl chloride 

Downstream Products

• 168412-13-3 cis-5-(2-acetoxy)ethylene-1-benzyl-4-nitroimidazole 
• 168412-08-6 1-benzyl-4-nitroimidazole-5-acetaldehyde (N²-carbomethoxy)hydrazone 
• 168412-09-7 1-benzyl-4-nitroimidazole-5-glyoxal (N²-methoxycarbonyl)hydrazone 
• 168412-11-1 4-amino-1-benzylimidazole-5-glyoxal (N²-methoxycarbonyl)hydrazone 
• 192379-41-2 4-amino-1-benzylimidazole-5-glyoxal (N²-benzyl)hydrazone 
• 168412-05-3 4-amino-1-benzylimidazole-5-glyoxal (N²-benzyl-N²-methoxycarbonyl)hydrazone 
• 192379-39-8 1-benzyl-4-nitroimidazole-5-glyoxal (N²-benzyl-N²-methoxycarbonyl)hydrazone 
• 505073-75-6 4-amino-1-benzylimidazole-5-glyoxal (N²-benzyl-N²-p-nitrophenoxycarbonyl)hydrazone 

Relevant academic research and scientific papers

Synthesis of a novel ring-expanded purine analogue containing a 5:8-fused imidazo[4,5-e][1,2,4]triazocine ring system amidst opportunistic rearrangements and ring transformations

A novel 5:8-fused heterocycle containing the imidazo[4,5-e][1,2,4]triazocine ring system has been synthesized in ten steps commencing from 1-benzyl-5-methyl-4-nitroimidazole. The compound is a new member of the family of ring-expanded xanthine-xanthosine analogues reported from this laboratory. The synthesis led to the unraveling of a number of novel rearrangements and ring-transformations.

Imidazo[4,5-e][1,2,4]Triazocine: A novel 5:8-fused ring system riddled with rearrangements

Attempts to synthesize the title 5:8-fused heterocyclic ring system resulted in a number of novel opportunistic rearrangements and transformations. There is, however, some evidence to believe that one of these rearrangements might proceed through the transient intermediacy of this ring system.